Results 201 to 210 of about 31,515 (266)

Real-life comparison of posaconazole versus fluconazole for primary antifungal prophylaxis during remission-induction chemotherapy for acute leukemia. [PDF]

open access: yesJ Assoc Med Microbiol Infect Dis Can, 2023
Dufresne SF   +7 more
europepmc   +1 more source

Decreasing Incidence of Candidemia Without Routine Systemic Antifungal Prophylaxis

open access: gold, 2015
Michael S. Calderwood   +4 more
openalex   +1 more source

Antifungal prophylaxis in high-risk patients with hematologic malignancy: a comparison of practice and guidelines in Türkiye. [PDF]

open access: yesTurk J Med Sci
Güzel Tunçcan Ö   +10 more
europepmc   +1 more source

1736. Evaluation of Targeted vs. Universal Antifungal Prophylaxis (AP) for Invasive Fungal Infections (IFI) After Lung Transplant (LTx) [PDF]

open access: gold, 2019
Kathleen A. Linder   +5 more
openalex   +1 more source

(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations [PDF]

open access: yes, 2018
Della Pepa, R.   +11 more
core   +1 more source

Evaluation of Posaconazole Therapeutic Drug Monitoring for Antifungal Prophylaxis in Hematology Patients at a Tertiary Referral Center

open access: hybrid
Aadith Ashok   +5 more
openalex   +1 more source

Antifungal prophylaxis for severely neutropenic chemotherapy recipients [PDF]

open access: bronze, 2002
Eric J. Bow   +5 more
openalex   +1 more source

Invasive fungal disease and antifungal prophylaxis in children with acute leukaemia: a multicentre retrospective Australian cohort study. [PDF]

open access: yesLancet Reg Health West Pac
Yeoh DK   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy